Norges Bank’s Pulmonx LUNG Stock Holding History

Norges Bank’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-151,200	Closed	-$392K	–	894
2025 Q2	$392K	Hold	151,200	–	–	﹤0.01%	1648
2025 Q1	$1.02M	Hold	151,200	–	–	﹤0.01%	1620
2024 Q4	$1.03M	Hold	151,200	–	–	﹤0.01%	1759
2024 Q3	$1.25M	Hold	151,200	–	–	﹤0.01%	1708
2024 Q2	$959K	Hold	151,200	–	–	﹤0.01%	1818
2024 Q1	$1.4M	Sell	151,200 -225,700	-60%	-$2.65M	﹤0.01%	1769
2023 Q4	$4.81M	Hold	376,900	–	–	﹤0.01%	1683
2023 Q3	$3.89M	Sell	376,900 -400	-0.1%	-$4.63K	﹤0.01%	1731
2023 Q2	$4.95M	Buy	377,300 +151,200	+67%	+$1.85M	﹤0.01%	1717
2023 Q1	$2.53M	Sell	226,100 -148,000	-40%	-$1.46M	﹤0.01%	1892
2022 Q4	$3.15M	Buy	374,100 +148,000	+65%	+$1.41M	﹤0.01%	1894
2022 Q3	$3.77M	Sell	226,100 -7,000	-3%	-$129K	﹤0.01%	1819
2022 Q2	$3.43M	Buy	+233,100	New	+$4.8M	﹤0.01%	1829
2022 Q1	–	Sell	-40,880	Closed	-$1.31M	–	2209
2021 Q4	$1.31M	Hold	40,880	–	–	﹤0.01%	2077
2021 Q3	$1.47M	Buy	40,880 +12,080	+42%	+$475K	﹤0.01%	2101
2021 Q2	$1.27M	Buy	+28,800	New	+$1.25M	﹤0.01%	2079

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Norges Bank's LUNG Position: Q3 2025 in Review

Norges Bank sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 151,200 shares — an estimated $392K sold.

Norges Bank first reported a position in LUNG in Q2 2021 and held it in 16 quarters. The position peaked at $4.95M in Q2 2023. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

Norges Bank reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
Norges Bank sold 151,200 Pulmonx shares in Q3 2025, an estimated $392K.
Norges Bank first reported a position in Pulmonx in Q2 2021 and held it in 16 quarters.
Norges Bank's Pulmonx position peaked at $4.95M in Q2 2023.
107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.